Frequency Electronics is the week's defining tension: a stock that rallied 17% in a single session on Thursday, against a backdrop of shorts who had been quietly rebuilding positions over the prior month and are now sitting on a painful squeeze.
The catalyst was earnings. FEIM reported on July 15, and despite the initial move showing a modest negative 1-day reaction in the history data, the market found its footing quickly — Thursday's 17% surge to $65.90 tells the real story of where conviction settled. The one-month chart still shows a 6% loss, meaning this week's move is essentially a violent mean-reversion after a soft stretch through June and early July. Peers moved in the opposite direction: LPTH fell 11% on the week, AEVA dropped 20%, and UMAC shed 10%. FEIM's divergence from that peer weakness makes the move all the more striking.
The squeeze dynamic is real, even if not extreme. Short interest climbed to 9.1% of free float — up 18% over the past month and up another 9.5% in the latest daily reading to roughly 886,000 shares short. Shorts had been pressing the position through a flat-to-lower June, and Thursday's gap higher caught them leaning the wrong way. That said, the borrow market is not screaming distress. Cost to borrow is a negligible 0.5%, and availability is still relatively loose at 162% — meaning there are roughly 1.6 shares available to lend for every share already borrowed. Shorts face mark-to-market pain but not a structural squeeze from the lending side. The ORTEX short score has climbed to 66.3, its highest reading of the past two weeks, reflecting the rising short interest even as the stock ripped higher — an uncomfortable combination for anyone short into this move.
Options positioning adds a mild contrarian note. The put/call ratio edged up to 0.24, nearly 1.8 standard deviations above its 20-day average of 0.20 — not a panicked reading, but a measured increase in hedging demand that arrived just as the stock broke higher. Given that the 52-week PCR high is 0.80, the current level is nowhere near distressed territory; it reads more like a small number of participants buying insurance into a print that turned out bullish for the stock.
On the Street, coverage is thin. Freedom Broker upgraded FEIM to Buy in May with a $65 target — essentially spot price before Thursday's move — having previously downgraded and then re-upgraded the name multiple times over the past year. That target is now stale relative to the current price. Craig-Hallum initiated at Buy with a $43 target in September 2025, a level the stock has now blown well past. The factor picture is mixed: EPS surprise ranks in just the 4th percentile, suggesting the company has a history of missing expectations, which makes the market's positive post-earnings re-rating more notable. Sector positioning scores at the 50th percentile — squarely average — while short score rank sits in the bottom decile of the universe, flagging elevated short pressure.
Institutionally, the ownership base is concentrated. Edenbrook Capital holds a dominant 19% stake with no recent change, providing a stable anchor. Driehaus added nearly 179,000 shares as of March, while Goldman built a position of 246,000 shares — both meaningful additions for a stock with a thin float. The next earnings event is pencilled in for September 11, which sets the clock on how long this post-print momentum needs to hold before the market resets its expectations again.
What to watch now is whether short interest — still elevated at 9.1% of float and rising — begins to unwind in the sessions ahead, or whether fresh sellers step in at the new $65-plus level to rebuild a position against a stock that remains well above its previous analyst targets.
See the live data behind this article on ORTEX.
Open FEIM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
